iRhythm Technologies, Inc. (IRTC) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in San Francisco, CA, United States. Der aktuelle CEO ist Quentin S. Blackford.
IRTC hat IPO-Datum 2016-10-20, 2,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $3.98B.
iRhythm Technologies, Inc. is a digital healthcare company headquartered in San Francisco that specializes in ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias in the United States. The company's flagship Zio service combines wire-free, patch-based wearable biosensors with a cloud-based analytics platform to enable physicians to continuously monitor patients and diagnose cardiac arrhythmias. Its Zio XT and AT monitors are single-use, wearable patches that record patient heartbeats and ECG data for clinical analysis. iRhythm also collaborates with Verily Life Sciences to develop next-generation atrial fibrillation detection and monitoring products, positioning itself at the intersection of wearable technology and cardiac care.
